NMDA Antagonist

NMDA Antagonist (N-Methyl-D-Aspartate receptor antagonist) refers to a specialized class of anesthetic and analgesic compounds that work by inhibiting the action of the NMDA receptor—a critical glutamate receptor in the central nervous system. By blocking the binding of the excitatory neurotransmitter glutamate, these agents induce a state of “dissociative anesthesia,” characterized by profound analgesia, sedation, and amnesia without suppressing vital respiratory or circulatory functions.

At LyfeUnit, we provide high-purity NMDA receptor antagonists, including Ketamine Hydrochloride (CAS 1867-66-9) in both liquid and crystalline salt forms. These compounds are essential for advanced clinical research into treatment-resistant depression (TRD), chronic neuropathic pain, and neuroplasticity. Our products are HPLC-verified to ensure 99.9% purity, meeting the rigorous demands of laboratory and veterinary professionals worldwide.

• Primary Mechanism: Inhibition of ionotropic glutamate receptors.

   

• Clinical Applications: General anesthesia, perioperative pain management, and psychiatric research.

   

• Pharmacological Profile: Non-competitive channel blockade for predictable dissociative effects.

   

• Quality Standard: Pharmaceutical USP/BP Grade chemicals.

• Procurement: Secure, discreet worldwide shipping with 100% delivery guarantee.

Explore LyfeUnit’s certified range of NMDA Antagonists for high-precision medical and research applications.